Therefore, we sought to assessed the possible prognostic and predictive role(s) of CYP2D6 polymorphisms in metastatic and/or locally recurrent inoperable breast cancer patients from Egypt who were treated with Tamoxifen. The gene discussed is CYP2D6; the disease is breast cancer.